MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CANF Can-Fite BioPharma Ltd Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology
CANF
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For CANF
(Try 14 days for $1 only)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CANF
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For CANF
(Try 14 days for $1 only)
Ad is loading...
A.I. Advisor
published Earnings

CANF is expected to report earnings to rise 767.00% to -8 cents per share on March 23

Can-Fite BioPharma Ltd CANF Stock Earnings Reports
Q4'22
Est.
$-0.09
Q3'22
Beat
by $0.08
Q2'22
Beat
by $0.04
Q1'22
Beat
by $0.14
The last earnings report on November 25 showed earnings per share of 0 cents, beating the estimate of -9 cents. With 12.91K shares outstanding, the current market capitalization sits at 13.37M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CANF and Stocks

Correlation & Price change

A.I.dvisor tells us that CANF and LGVN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANF and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
N/A
LGVN - CANF
33%
Poorly correlated
+0.98%
RNA - CANF
30%
Poorly correlated
-6.84%
XENE - CANF
26%
Poorly correlated
-0.47%
VRNA - CANF
25%
Poorly correlated
-0.98%
ZLAB - CANF
25%
Poorly correlated
-2.96%
More

Groups containing CANF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
N/A
diseases
theme (42 stocks)
24%
Poorly correlated
+1.03%
cancer
theme (87 stocks)
23%
Poorly correlated
+0.89%
drugs
theme (265 stocks)
23%
Poorly correlated
+5.37%
biotechnology
theme (248 stocks)
21%
Poorly correlated
+5.56%
biopharmaceuticals
theme (52 stocks)
20%
Poorly correlated
+2.00%
More